Early treatment of avascular necrosis in systemic lupus erythematosus
- PMID: 3740994
- PMCID: PMC1001961
- DOI: 10.1136/ard.45.8.649
Early treatment of avascular necrosis in systemic lupus erythematosus
Abstract
Avascular necrosis (AVN) of the hips is associated with significant disability, and the majority of established cases require major surgery. In a retrospective analysis of 185 patients with systemic lupus erythematosus (SLE) 13 (7%) were found to have AVN. Of these, six had Raynaud's phenomenon, all had been on corticosteroids, and one had digital vasculitis. The mean duration of corticosteroid therapy was two years (range four months to five years). Five patients developed AVN two to 10 years after discontinuing steroids. The mean duration of disease at the onset of AVN was 6.85 years (range 1-19 years), and the mean age at onset of AVN was 31 years. Ten patients had severe multisystem involvement. None of the patients abused alcohol. Surgery was performed on 11 hips. Three had total hip replacement for stages 3 and 4 and seven had core decompression for stages 1 and 2. AVN progressed in two (28%) of these patients. In another patient core decompression failed for technical reasons. She subsequently required total hip replacement. The early detection of AVN to avoid the need for major surgery is stressed.
Similar articles
-
Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.Rheumatol Int. 2012 Jan;32(1):177-82. doi: 10.1007/s00296-010-1597-9. Epub 2010 Aug 15. Rheumatol Int. 2012. PMID: 20711782
-
Clinically occult avascular necrosis of the hip in systemic lupus erythematosus.J Rheumatol. 1997 Dec;24(12):2318-22. J Rheumatol. 1997. PMID: 9415635
-
Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus.J Rheumatol. 2000 Apr;27(4):919-23. J Rheumatol. 2000. PMID: 10782816 Clinical Trial.
-
A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors.Clin Exp Rheumatol. 2017 Jul-Aug;35(4):700-710. Epub 2017 Feb 24. Clin Exp Rheumatol. 2017. PMID: 28240590 Review.
-
Total hip arthroplasty in secondary systemic lupus erythematosus femoral head avascular necrosis.Rom J Intern Med. 2007;45(1):123-9. Rom J Intern Med. 2007. PMID: 17966453 Review.
Cited by
-
Laminar periostitis and multiple osteonecrosis in systemic lupus erythematosus.Clin Rheumatol. 1990 Dec;9(4):535-8. doi: 10.1007/BF02030518. Clin Rheumatol. 1990. PMID: 2088652
-
Screening for Asymptomatic Osteonecrosis of the Hip in Systemic Lupus Erythematous: A Systematic Review and Meta-Analysis of MRI-Based Prevalence.Diagnostics (Basel). 2024 Jan 27;14(3):279. doi: 10.3390/diagnostics14030279. Diagnostics (Basel). 2024. PMID: 38337795 Free PMC article. Review.
-
Osteonecrosis in patients with SLE.Clin Rev Allergy Immunol. 2003 Aug;25(1):13-24. doi: 10.1385/CRIAI:25:1:13. Clin Rev Allergy Immunol. 2003. PMID: 12794257 Review.
-
Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients.Clin Transl Med. 2021 Oct;11(10):e526. doi: 10.1002/ctm2.526. Clin Transl Med. 2021. PMID: 34709753 Free PMC article. Review.
-
Management of Scleritis in Older Adults.Drugs Aging. 2024 Apr;41(4):287-302. doi: 10.1007/s40266-024-01105-0. Epub 2024 Mar 5. Drugs Aging. 2024. PMID: 38441778 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical